Colin Howe

2.4k total citations · 2 hit papers
18 papers, 1.8k citations indexed

About

Colin Howe is a scholar working on Physiology, Molecular Biology and Applied Psychology. According to data from OpenAlex, Colin Howe has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 7 papers in Molecular Biology and 5 papers in Applied Psychology. Recurrent topics in Colin Howe's work include Smoking Behavior and Cessation (13 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Behavioral Health and Interventions (5 papers). Colin Howe is often cited by papers focused on Smoking Behavior and Cessation (13 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Behavioral Health and Interventions (5 papers). Colin Howe collaborates with scholars based in New Zealand, United Kingdom and Australia. Colin Howe's co-authors include Chris Bullen, Murray Laugesen, Natalie Walker, Hayden McRobbie, Varsha Parag, Jonathan Williman, Marewa Glover, Vili Nosa, Joanne Barnes and Robyn Whittaker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Colin Howe

18 papers receiving 1.7k citations

Hit Papers

Electronic cigarettes for smoking cessation: a randomised... 2013 2026 2017 2021 2013 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Howe New Zealand 13 1.4k 694 292 282 156 18 1.8k
Jasjit S. Ahluwalia United States 17 838 0.6× 405 0.6× 278 1.0× 121 0.4× 66 0.4× 26 1.4k
Peggy O’Hara United States 14 615 0.4× 238 0.3× 163 0.6× 107 0.4× 69 0.4× 18 1.1k
Jonathan Livingstone‐Banks United Kingdom 21 1.2k 0.9× 458 0.7× 394 1.3× 185 0.7× 81 0.5× 53 1.6k
Pasquale Caponnetto Italy 16 797 0.6× 291 0.4× 221 0.8× 111 0.4× 120 0.8× 46 1.2k
Eva Králíková Czechia 18 576 0.4× 236 0.3× 136 0.5× 167 0.6× 64 0.4× 89 996
Bradley Rosbrook United States 14 1.4k 1.0× 549 0.8× 573 2.0× 72 0.3× 85 0.5× 17 1.8k
Rebecca Williams United States 13 788 0.6× 514 0.7× 170 0.6× 63 0.2× 127 0.8× 33 1.1k
LF Stead United Kingdom 15 1.1k 0.8× 429 0.6× 319 1.1× 250 0.9× 23 0.1× 21 1.5k
Katie Myers Smith United Kingdom 18 1.4k 1.0× 623 0.9× 298 1.0× 222 0.8× 251 1.6× 36 1.8k

Countries citing papers authored by Colin Howe

Since Specialization
Citations

This map shows the geographic impact of Colin Howe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Howe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Howe more than expected).

Fields of papers citing papers by Colin Howe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Howe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Howe. The network helps show where Colin Howe may publish in the future.

Co-authorship network of co-authors of Colin Howe

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Howe. A scholar is included among the top collaborators of Colin Howe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Howe. Colin Howe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Howe, Colin, et al.. (2017). Altered juvenile fish communities associated with invasive Halophila stipulacea seagrass habitats in the U.S. Virgin Islands. PLoS ONE. 12(11). e0188386–e0188386. 17 indexed citations
2.
Walker, Natalie, Colin Howe, Marewa Glover, et al.. (2015). Cytisine Versus Nicotine for Smoking Cessation. Obstetrical & Gynecological Survey. 70(4). 255–256. 8 indexed citations
3.
Arboleda, Enrique, et al.. (2015). The effect of recreational SCUBA divers on the structural complexity and benthic assemblage of a Caribbean coral reef. Biodiversity and Conservation. 24(14). 3491–3504. 26 indexed citations
4.
Walker, Neil J., Colin Howe, & Marewa Glover. (2015). Cytisine Versus Nicotine for Smoking Cessation. Journal of Vascular Surgery. 61(3). 837–837. 5 indexed citations
5.
Bullen, Chris, Colin Howe, & Murray Laugesen. (2014). Electronic Cigarettes for Smoking Cessation: A Randomised Controlled Trial. Journal of Vascular Surgery. 59(3). 872–872. 324 indexed citations breakdown →
6.
Walker, Natalie, Colin Howe, Marewa Glover, et al.. (2014). Cytisine versus Nicotine for Smoking Cessation. New England Journal of Medicine. 371(25). 2353–2362. 151 indexed citations
7.
Walker, Natalie, Colin Howe, Murray Laugesen, et al.. (2014). Abrupt nicotine reduction as an endgame policy: a randomised trial. Tobacco Control. 24(e4). e251–e257. 18 indexed citations
8.
Bullen, Chris, Jonathan Williman, Colin Howe, et al.. (2013). Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 13(1). 210–210. 71 indexed citations
9.
Bullen, Chris, Colin Howe, Murray Laugesen, et al.. (2013). Electronic cigarettes for smoking cessation: a randomised controlled trial. The Lancet. 382(9905). 1629–1637. 838 indexed citations breakdown →
11.
Walker, Natalie, Colin Howe, Chris Bullen, et al.. (2011). Study protocol for a randomised trial of nicotine-free cigarettes as an adjunct to usual NRT-based cessation practice, in people who wish to stop smoking. BMC Public Health. 11(1). 37–37. 8 indexed citations
12.
Walker, Natalie, Colin Howe, Chris Bullen, et al.. (2011). Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial. Addiction. 106(6). 1176–1185. 34 indexed citations
13.
Walker, Natalie, Colin Howe, Chris Bullen, et al.. (2011). Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking. BMC Public Health. 11(1). 880–880. 15 indexed citations
14.
Bullen, Chris, Colin Howe, Ruey‐Bin Lin, et al.. (2010). Pre‐cessation nicotine replacement therapy: pragmatic randomized trial. Addiction. 105(8). 1474–1483. 49 indexed citations
15.
Poppitt, Sally D., Colin Howe, Fiona E. Lithander, et al.. (2009). Effects of Moderate-Dose Omega-3 Fish Oil on Cardiovascular Risk Factors and Mood After Ischemic Stroke. Stroke. 40(11). 3485–3492. 47 indexed citations
16.
Bullen, Chris, et al.. (2008). Recruitment Into a Cessation Trial Via the New Zealand Quitline: Many Benefits, Few Limitations. The Journal of Smoking Cessation. 3(1). 30–34. 6 indexed citations
17.
Anderson, Craig S., Colin Howe, Fiona E. Lithander, et al.. (2008). The fish oils in ischemic stroke (FOILS) study: a randomised controlled trial. 2 indexed citations
18.
Opravil, Milos, Bernard Hirschel, Adriano Lazzarin, et al.. (2002). A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 185(9). 1251–1260. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026